Long-term safety of darolutamide among patients with metastatic castration-resistant prostate cancer who received more than 4 years of therapy

Robert Hugh Jones; Karim Fizazi; Nicholas James D; Teuvo Tammela; Nobuaki Matsubara; Frank Priou; Phillipe Beuzeboc; Thierry Lesimple; Petri Bono; Vesa Kataja; Jorge A. Garcia; Andrew Protheroe; John Aspegren; Heikki Joensuu; Iris Kuss; Silke Thiele; Sabine Fiala-Buskies; Egils Vjaters

Long-term safety of darolutamide among patients with metastatic castration-resistant prostate cancer who received more than 4 years of therapy

Robert Hugh Jones, Karim Fizazi, Nicholas James D, Teuvo Tammela, Nobuaki Matsubara, Frank Priou, Phillipe Beuzeboc, Thierry Lesimple, Petri Bono, Vesa Kataja, Jorge A. Garcia, Andrew Protheroe, John Aspegren, Heikki Joensuu, Iris Kuss, Silke Thiele, Sabine Fiala-Buskies, Egils Vjaters

Research output: Other conference contribution › Abstract › Scientific

Original language	English
Publication status	Published - 14 May 2022
Publication type	Not Eligible
Event	American Urological Association 2022 AUA Annual Meeting - New Orleans, United States Duration: 13 May 2022 → 16 May 2022 https://www.auanet.org/annualmeeting

Conference

Conference	American Urological Association 2022 AUA Annual Meeting
Country/Territory	United States
City	New Orleans
Period	13/05/22 → 16/05/22
Internet address	https://www.auanet.org/annualmeeting

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://app.swapcard.com/event/2022-aua-annual-meeting-new-orleans/planning/UGxhbm5pbmdfODc5NDk0

Cite this

Jones, R. H., Fizazi, K., James D, N., Tammela, T., Matsubara, N., Priou, F., Beuzeboc, P., Lesimple, T., Bono, P., Kataja, V., Garcia, J. A., Protheroe, A., Aspegren, J., Joensuu, H., Kuss, I., Thiele, S., Fiala-Buskies, S., & Vjaters, E. (2022). Long-term safety of darolutamide among patients with metastatic castration-resistant prostate cancer who received more than 4 years of therapy. Abstract from American Urological Association
2022 AUA Annual Meeting, New Orleans, Louisiana, United States. https://app.swapcard.com/event/2022-aua-annual-meeting-new-orleans/planning/UGxhbm5pbmdfODc5NDk0

@conference{a38d46fc520e4bfaa86d3f989c30b7df,

title = "Long-term safety of darolutamide among patients with metastatic castration-resistant prostate cancer who received more than 4 years of therapy",

author = "Jones, {Robert Hugh} and Karim Fizazi and {James D}, Nicholas and Teuvo Tammela and Nobuaki Matsubara and Frank Priou and Phillipe Beuzeboc and Thierry Lesimple and Petri Bono and Vesa Kataja and Garcia, {Jorge A.} and Andrew Protheroe and John Aspegren and Heikki Joensuu and Iris Kuss and Silke Thiele and Sabine Fiala-Buskies and Egils Vjaters",

year = "2022",

month = may,

day = "14",

language = "English",

note = "American Urological Association<br/>2022 AUA Annual Meeting ; Conference date: 13-05-2022 Through 16-05-2022",

url = "https://www.auanet.org/annualmeeting",

}

Jones, RH, Fizazi, K, James D, N, Tammela, T, Matsubara, N, Priou, F, Beuzeboc, P, Lesimple, T, Bono, P, Kataja, V, Garcia, JA, Protheroe, A, Aspegren, J, Joensuu, H, Kuss, I, Thiele, S, Fiala-Buskies, S & Vjaters, E 2022, 'Long-term safety of darolutamide among patients with metastatic castration-resistant prostate cancer who received more than 4 years of therapy', American Urological Association
2022 AUA Annual Meeting, New Orleans, United States, 13/05/22 - 16/05/22. <https://app.swapcard.com/event/2022-aua-annual-meeting-new-orleans/planning/UGxhbm5pbmdfODc5NDk0>

Long-term safety of darolutamide among patients with metastatic castration-resistant prostate cancer who received more than 4 years of therapy. / Jones, Robert Hugh; Fizazi, Karim; James D, Nicholas et al.
2022. Abstract from American Urological Association
2022 AUA Annual Meeting, New Orleans, Louisiana, United States.

Research output: Other conference contribution › Abstract › Scientific

TY - CONF

T1 - Long-term safety of darolutamide among patients with metastatic castration-resistant prostate cancer who received more than 4 years of therapy

AU - Jones, Robert Hugh

AU - Fizazi, Karim

AU - James D, Nicholas

AU - Tammela, Teuvo

AU - Matsubara, Nobuaki

AU - Priou, Frank

AU - Beuzeboc, Phillipe

AU - Lesimple, Thierry

AU - Bono, Petri

AU - Kataja, Vesa

AU - Garcia, Jorge A.

AU - Protheroe, Andrew

AU - Aspegren, John

AU - Joensuu, Heikki

AU - Kuss, Iris

AU - Thiele, Silke

AU - Fiala-Buskies, Sabine

AU - Vjaters, Egils

PY - 2022/5/14

Y1 - 2022/5/14

M3 - Abstract

T2 - American Urological Association<br/>2022 AUA Annual Meeting

Y2 - 13 May 2022 through 16 May 2022

ER -